Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Recombinant glycoprotein gp350 of Epstein-Barr virus

EU orphan designation number: EU/3/02/118   
Active ingredient: Recombinant glycoprotein gp350 of Epstein-Barr virus
Indication: Prevention of post transplantation lympho-proliferative disorders
Sponsor: Henogen S.A.
12 rue des Professeurs Jeener et Brachet, 6041 Gosselies (Charleroi), Belgique

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
24/10/2002 Orphan designation EMEA/OD/043/01 (2002)4122 of 22/10/2002